These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7542677)

  • 1. Prophylactic potential of selective reuptake inhibitors in suicidal patients.
    Banki CM
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():61-5. PubMed ID: 7542677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
    Sheline Y; Bardgett ME; Csernansky JG
    J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia.
    Cooper SJ; Kelly CB; King DJ
    Lancet; 1992 Oct; 340(8825):940-1. PubMed ID: 1383659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid monoamine metabolites and suicide.
    Jokinen J; Nordström AL; Nordström P
    Nord J Psychiatry; 2009; 63(4):276-9. PubMed ID: 19034712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters.
    Moberg T; Nordström P; Forslund K; Kristiansson M; Asberg M; Jokinen J
    J Affect Disord; 2011 Jul; 132(1-2):173-8. PubMed ID: 21356560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicide prevention and serotonergic drugs.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters.
    Chatzittofis A; Nordström P; Hellström C; Arver S; Åsberg M; Jokinen J
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1280-7. PubMed ID: 23453639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol, CSF 5-HIAA, violence and intent in suicidal men.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2010 Jun; 178(1):217-9. PubMed ID: 20452040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters.
    Westrin A; Niméus A
    Eur Psychiatry; 2003 Jun; 18(4):166-71. PubMed ID: 12814849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients.
    Mann JJ; Malone KM; Sweeney JA; Brown RP; Linnoila M; Stanley B; Stanley M
    Neuropsychopharmacology; 1996 Dec; 15(6):576-86. PubMed ID: 8946432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin conductance habituation and cerebrospinal fluid 5-hydroxyindoleacetic acid in suicidal patients.
    Edman G; Asberg M; Levander S; Schalling D
    Arch Gen Psychiatry; 1986 Jun; 43(6):586-92. PubMed ID: 2423049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients.
    Mann JJ; Malone KM
    Biol Psychiatry; 1997 Jan; 41(2):162-71. PubMed ID: 9018386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminergic studies and cerebrospinal fluid cations in suicide.
    Banki CM; Arató M; Kilts CD
    Ann N Y Acad Sci; 1986; 487():221-30. PubMed ID: 2436535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression.
    Spreux-Varoquaux O; Alvarez JC; Berlin I; Batista G; Despierre PG; Gilton A; Cremniter D
    Life Sci; 2001 Jun; 69(6):647-57. PubMed ID: 11476186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L; Asberg M; Bertilsson L; Sjöstrand L
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
    Jokinen J; Mårtensson B; Nordström AL; Nordström P
    J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters.
    Jokinen J; Samuelsson M; Nordström AL; Nordström P
    J Affect Disord; 2008 Nov; 111(1):119-24. PubMed ID: 18342374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.